awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28077411-8F0153B6-0FE6-4432-BE0B-E6FE6742B9D3
Q28077411-8F0153B6-0FE6-4432-BE0B-E6FE6742B9D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077411-8F0153B6-0FE6-4432-BE0B-E6FE6742B9D3
Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms
P2860
Q28077411-8F0153B6-0FE6-4432-BE0B-E6FE6742B9D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077411-8F0153B6-0FE6-4432-BE0B-E6FE6742B9D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ecd4fda05e9ccf52ba45a85a4731d0a9136e721
P2860
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.